Cargando…
Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
Dementia affects about 47 million people worldwide, number expected to exponentially increase within 30 years. Alzheimer’s disease (AD) is the most common dementia type, accounting on its own for almost 70% of all dementia cases. Behavioral and psychological symptoms (BPSD) frequently occur during t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002184/ https://www.ncbi.nlm.nih.gov/pubmed/33803277 http://dx.doi.org/10.3390/ph14030246 |
_version_ | 1783671404306104320 |
---|---|
author | Calsolaro, Valeria Femminella, Grazia Daniela Rogani, Sara Esposito, Salvatore Franchi, Riccardo Okoye, Chukwuma Rengo, Giuseppe Monzani, Fabio |
author_facet | Calsolaro, Valeria Femminella, Grazia Daniela Rogani, Sara Esposito, Salvatore Franchi, Riccardo Okoye, Chukwuma Rengo, Giuseppe Monzani, Fabio |
author_sort | Calsolaro, Valeria |
collection | PubMed |
description | Dementia affects about 47 million people worldwide, number expected to exponentially increase within 30 years. Alzheimer’s disease (AD) is the most common dementia type, accounting on its own for almost 70% of all dementia cases. Behavioral and psychological symptoms (BPSD) frequently occur during the disease progression; to treat agitation, aggressiveness, delusions and hallucinations, the use of antipsychotic drugs should be limited, due to their safety issues. In this literature review regarding the use of antipsychotics for treating BPSD in dementia, the advantages and limitation of antipsychotic drugs have been evaluated. The available medications for the management of behavioral and psychological symptoms are the antipsychotics, classed into typical and atypical, depending on their action on dopamine and serotonin receptors. First generation, or typical, antipsychotics exhibit lack of tolerability and display a broad range of side effects such as sedation, anticholinergic effects and extrapyramidal symptoms. Atypical, or second generation, antipsychotics bind more selectively to dopamine receptors and simultaneously block serotonin receptors, resulting in higher tolerability. High attention should be paid to the management of therapy interruption or switch between antipsychotics, to limit the possible rebound effect. Several switching strategies may be adopted, and clinicians should “tailor” therapies, accounting for patients’ symptoms, comorbidities, polytherapies and frailty. |
format | Online Article Text |
id | pubmed-8002184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80021842021-03-28 Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics Calsolaro, Valeria Femminella, Grazia Daniela Rogani, Sara Esposito, Salvatore Franchi, Riccardo Okoye, Chukwuma Rengo, Giuseppe Monzani, Fabio Pharmaceuticals (Basel) Review Dementia affects about 47 million people worldwide, number expected to exponentially increase within 30 years. Alzheimer’s disease (AD) is the most common dementia type, accounting on its own for almost 70% of all dementia cases. Behavioral and psychological symptoms (BPSD) frequently occur during the disease progression; to treat agitation, aggressiveness, delusions and hallucinations, the use of antipsychotic drugs should be limited, due to their safety issues. In this literature review regarding the use of antipsychotics for treating BPSD in dementia, the advantages and limitation of antipsychotic drugs have been evaluated. The available medications for the management of behavioral and psychological symptoms are the antipsychotics, classed into typical and atypical, depending on their action on dopamine and serotonin receptors. First generation, or typical, antipsychotics exhibit lack of tolerability and display a broad range of side effects such as sedation, anticholinergic effects and extrapyramidal symptoms. Atypical, or second generation, antipsychotics bind more selectively to dopamine receptors and simultaneously block serotonin receptors, resulting in higher tolerability. High attention should be paid to the management of therapy interruption or switch between antipsychotics, to limit the possible rebound effect. Several switching strategies may be adopted, and clinicians should “tailor” therapies, accounting for patients’ symptoms, comorbidities, polytherapies and frailty. MDPI 2021-03-09 /pmc/articles/PMC8002184/ /pubmed/33803277 http://dx.doi.org/10.3390/ph14030246 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Review Calsolaro, Valeria Femminella, Grazia Daniela Rogani, Sara Esposito, Salvatore Franchi, Riccardo Okoye, Chukwuma Rengo, Giuseppe Monzani, Fabio Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics |
title | Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics |
title_full | Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics |
title_fullStr | Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics |
title_full_unstemmed | Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics |
title_short | Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics |
title_sort | behavioral and psychological symptoms in dementia (bpsd) and the use of antipsychotics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002184/ https://www.ncbi.nlm.nih.gov/pubmed/33803277 http://dx.doi.org/10.3390/ph14030246 |
work_keys_str_mv | AT calsolarovaleria behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT femminellagraziadaniela behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT roganisara behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT espositosalvatore behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT franchiriccardo behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT okoyechukwuma behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT rengogiuseppe behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics AT monzanifabio behavioralandpsychologicalsymptomsindementiabpsdandtheuseofantipsychotics |